Taken together, these observations demonstrate that increased expression of NSD2 is associated with lethal and metastatic prostate cancer, and establish the functional relevance of NSD2 for metastatic prostate cancer progression. The gene discussed is NSD2; the disease is metastatic prostate carcinoma.